NDC 0955-2900-01 - Insulin glargine U-300
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0955-2900
- Requested NDC
- 0955-2900-01
- Package NDCs from labels
- 0955-2900-01, 0955-2900-02
- Manufacturer
- Sanofi-Aventis U.S. LLC | Genzyme Corporation | Sanofi-Aventis Deutschland GmbH
- Effective date
- 2025-05-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Insulin glargine U-300 - Sanofi-Aventis U.S. LLC | Genzyme Corporation | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis U.S. LLC | Genzyme Corporation | Sanofi-Aventis Deutschland GmbH | 2025-05-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0955-2900-01 | Insulin glargine U-300 Max | 3 mL in 1 SYRINGE | INJECTION, SOLUTION | 3 | 7 | |
| 0955-2900-02 | Insulin glargine U-300 Max | 2 in 1 CARTON | INJECTION, SOLUTION | 2 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0955-2900 | INSULIN GLARGINE U-300 (INSULIN GLARGINE) INJECTION, SOLUTION INSULIN GLARGINE U-300 MAX (INSULIN GLARGINE) INJECTION, SOLUTION [WINTHROP U.S.] | 6 | Current NDC, 2 package rows | 20240913_99ea856d-9562-443a-9422-1006a3cff2f4.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0955-2900-01 | ML - Milliliter | 0955-2900 | d5f1116f-3b0d-4a22-b902-789dc1133f55 | 1 | 2024-02-14 |
| 0955-2900-02 | ML - Milliliter | 0955-2900 | 6dda0158-cc5b-4530-884a-73ea65000a7e | 1 | 2024-02-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glycerin | GLYCERIN | Amerisource Bergen/Good Neighbor Pharmacy | 90a4d385-d548-420b-91d2-54d5e819fcce | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | CVS Pharmacy | 3a59c4a9-5f86-406a-e054-00144ff8d46c | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Cardinal Health | 7e7e9366-af1e-e0ff-e053-2a91aa0a9487 | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Cardinal Health | c2b02afc-5a8a-2a25-e053-2a95a90ae45c | 2025-10-24 | Warnings | PDC6A3C0OX |
| Signature Care Hemorrhoidal Cream (with applicator) | PHENYLEPHRINE HYDROCHLORIDE, PRAMOXINE HYDROCHLORIDE, GLYCERIN, PETROLATUM | BETTER LIVING BRANDS, LLC | b026a386-5e38-52ed-e053-2a95a90a6b0e | 2025-10-24 | Warnings | PDC6A3C0OX |
| Lemon Glycerine Swabsticks | GLYCERINE | PHOENIX HEALTHCARE SOLUTIONS, LLC | 436919f7-14cd-4318-9388-b3e1cbec176b | 2025-10-23 | Warnings | PDC6A3C0OX |
| Advanced Eye Relief Dry Eye Rejuvenation | GLYCERIN PROPYLENE GLYCOL | Bausch & Lomb Incorporated | 027969ee-64e4-4b08-bab7-c4cc8ed22f5f | 2025-10-23 | Warnings | PDC6A3C0OX |
| Sterile Water | WATER | Becton Dickinson and Company | cab03cda-4660-4020-a3be-bf86242ff664 | 2025-10-22 | Warnings, Adverse reactions | 059QF0KO0R |
| Refresh Relieva Preservative Free | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | 3481f9b3-5a90-40d3-80f8-81f51cc864be | 2025-10-22 | Warnings | PDC6A3C0OX |
| M-Natal Plus | VITAMIN A, VITAMIN C, VITAMIN D, VITAMIN E, THIAMINE, RIBOFLAVIN, NIACIN, VITAMIN B6, FOLIC ACID, VITAMIN B12, CALCIUM, IRON, ZINC, COPPER | METHOD PHARMACEUTICALS, LLC | 1f8785db-3e65-49d7-b017-b1a65b5ec6b1 | 2025-10-21 | Warnings | J41CSQ7QDS |
| Glycerin | GLYCERIN | Chain Drug Consortium LLC | 4694f05b-d927-4e15-9630-a0a1cddb3cbb | 2025-10-16 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Amerisource Bergen/Good Neighbor Pharmacy | e6a8914f-cfd9-4c72-abaa-22189bf0faef | 2025-10-16 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Chain Drug Marketing Association Inc. | 3386fada-6b7f-46fd-e063-6294a90abffc | 2025-10-16 | Warnings | PDC6A3C0OX |
| Finafta | BENZOCAINE, GLYCERIN | Efficient Laboratories Inc. | 03368603-3e11-c2fa-e063-6294a90a04ea | 2025-10-14 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | H E B | 3d0566a1-57a5-6a31-e054-00144ff88e88 | 2025-10-09 | Warnings | PDC6A3C0OX |
| Neuro Calming Formula | AVENA SATIVA, HUMULUS LUPULUS, PASSIFLORA INCARNATA, VALERIANA OFFICINALIS, IGNATIA AMARA, SCUTELLARIA LATERIFLORA, ZINCUM METALLICUM | Nutritional Specialties, Inc. | ff9b8811-1883-42bc-bcf4-7b390237a619 | 2025-10-08 | Warnings | J41CSQ7QDS |
| Mitochondria PRO | ARALIA QUINQUEFOLIA, ARNICA MONTANA, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ALPHA-KETOGLUTARICUM ACIDUM, ASCORBICUM ACIDUM, ALPHA-LIPOICUM ACIDUM, CALCAREA CARBONICA, CITRICUM ACIDUM, CUPRUM METALLICUM, CYSTEINUM, FERRUM METALLICUM, IODIUM, LEVOTHYROXINUM, MAGNESIUM GLUCONICUM DIHYDRICUM, MALICUM ACIDUM, MANGANUM ACETICUM, NADIDUM, NATRUM PYRUVICUM, NICOTINAMIDUM, PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, SELENIUM METALLICUM, SULPHUR, THIAMINUM HYDROCHLORICUM, UBIDECARENONUM, ZINCUM METALLICUM, | Energique, Inc. | 8c3e961d-bc33-40cd-a282-a4fe5aa3f0ad | 2025-10-06 | Warnings | J41CSQ7QDS |
| Xpect Industrial Eye Relief | GLYCERIN, NAPHAZOLINE HCL | Cintas Corporation | a0167d06-7adb-36f4-e053-2a95a90af9ef | 2025-09-30 | Warnings | PDC6A3C0OX |
| Xpect Eyewash | EYEWASH | Cintas Corporation | 1d69365d-662b-4248-8fa9-1629451b549a | 2025-09-30 | Warnings | 059QF0KO0R |
| CheBoho TEA TREE ACNE | CHEBOHO TEA TREE ACNE | Opalshi(Guangzhou)E-commerce Co. Ltd. | 3fc4cf84-b2da-c593-e063-6394a90abc5c | 2025-09-27 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.